Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma

Anil Potti, Nauman Moazzam, Ketki Tendulkar, Nazia Ali Javed, Michael Koch, Steve Kargas

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Background: Molecular changes associated with the transition of melanoma cells from radial to vertical growth phase are not defined. To evaluate the role of VEGF in melanogenesis and determine its possible diagnostic and prognostic implications, we analyzed overexpression of VEGF in 202 cases of melanoma. Materials and Methods: Overexpression of VEGF was evaluated in 202 archival paraffin-embedded tissue specimens using an avidin-biotin immunohistochemical (IHC) assay. Results: Of the 202 melanoma specimens, 42 (20.8%) showed evidence of VEGF overexpression on IHC testing. Multivariate analysis performed using Cox proportional hazards method did not show a statistically significant survival difference between the VEGF-positive and negative groups (p=0.25). Conclusion: Although of no significant prognostic value, VEGF may have critical therapeutic implications as a molecular target since it is expressed in about 20% of melanomas. The role of target-specific therapies against VEGF in malignant melanoma warrants further investigations.

Original languageEnglish (US)
Pages (from-to)4023-4026
Number of pages4
JournalAnticancer Research
Volume23
Issue number5 A
StatePublished - Sep 2003

Keywords

  • Immunohistochemistry
  • Malignant melanoma
  • Overexpression
  • Survival
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma'. Together they form a unique fingerprint.

  • Cite this